HEIDELBERG, Germany (AP) — HEIDELBERG, Germany (AP) — Affimed N.V. (AFMD) on Thursday reported a loss of $32 million in its second quarter.
On a per-share basis, the Heidelberg, Germany-based company said it had a loss of 22 cents.
The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 22 cents per share.
The drug developer posted revenue of $1.5 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $4.8 million.
The company's shares closed at 56 cents. A year ago, they were trading at $3.24.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AFMD at https://www.zacks.com/ap/AFMD
/Tesla%20Inc%20tesla%20by-%20Iv-olga%20via%20Shutterstock(1).jpg)
/Stickers%20with%20AMD%20Radeon%20and%20Nvidia%20GeForce%20RTX%20graphics%20on%20new%20laptop%20computer%20by%20Piotr%20Swat%20via%20Shutterstock.jpg)
/Nvidia%20logo%20by%20Konstantin%20Savusia%20via%20Shutterstock.jpg)